Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study-Reference-Cited by-同舟云学术

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Published:2006-10 Issue:10 Volume:28 Page:1556-1568
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Rosenstock Julio,Brazg Ronald,Andryuk Paula J.,Lu Kaifeng,Stein Peter

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans;Holst;Am J Physiol Endocrinol Metab,2004

2. Biological actions and therapeutic potential of the glucagon-like peptides;Drucker;Gastroenterology,2002

3. Therapeutic strategies based on glucagon-like peptide 1;Deacon;Diabetes,2004

4. What do we know about the secretion and degradation of incretin hormones?;Deacon;Regal Pept,2005

5. Inhibitors ofdipeptidyl peptidase IV. A novel approach for the prevention and treatment of type 2 diabetes?;Deacon;Expert Opin lnvestig Drugs,2004

Cited by 431 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS;Chemical Research in Toxicology;2024-04-29

2. Treatment Approaches and Challenges;Nanoscience Applications in Diabetes Treatment;2023-12-17

3. Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study;Scientific Reports;2023-01-04

4. Gut Hormones and Metabolic Syndrome;Metabolic Syndrome;2023

5. Gut Hormones and Metabolic Syndrome;Metabolic Syndrome;2023